Zichao Luo

3.1k total citations · 1 hit paper
51 papers, 2.5k citations indexed

About

Zichao Luo is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Zichao Luo has authored 51 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Biomedical Engineering and 18 papers in Immunology. Recurrent topics in Zichao Luo's work include Nanoplatforms for cancer theranostics (18 papers), Immunotherapy and Immune Responses (17 papers) and RNA Interference and Gene Delivery (13 papers). Zichao Luo is often cited by papers focused on Nanoplatforms for cancer theranostics (18 papers), Immunotherapy and Immune Responses (17 papers) and RNA Interference and Gene Delivery (13 papers). Zichao Luo collaborates with scholars based in China, Singapore and United Kingdom. Zichao Luo's co-authors include Xiaogang Liu, Zhigao Yi, Xingyi Li, Changyang Gong, Hao Chen, Yifan Ma, Hong Pan, Lanlan Liu, Tao He and Shuai Shi and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Zichao Luo

50 papers receiving 2.4k citations

Hit Papers

Mitochondria-Targeting Type-I Photodrug: Harnessing Caspa... 2024 2026 2025 2024 20 40 60

Peers

Zichao Luo
Evan A. Scott United States
Eiji Yuba Japan
Todd D. Giorgio United States
Conlin P. O’Neil Switzerland
Shaomin Tian United States
Zichao Luo
Citations per year, relative to Zichao Luo Zichao Luo (= 1×) peers Malou Henriksen‐Lacey

Countries citing papers authored by Zichao Luo

Since Specialization
Citations

This map shows the geographic impact of Zichao Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zichao Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zichao Luo more than expected).

Fields of papers citing papers by Zichao Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zichao Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zichao Luo. The network helps show where Zichao Luo may publish in the future.

Co-authorship network of co-authors of Zichao Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Zichao Luo. A scholar is included among the top collaborators of Zichao Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zichao Luo. Zichao Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yesi, Di Hu, Duyang Gao, et al.. (2025). Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy. Nature Nanotechnology. 21(1). 125–139.
2.
Liu, Yuxia, Duyang Gao, Yuanyuan He, et al.. (2024). Single-point mutated lanmodulin as a high-performance MRI contrast agent for vascular and kidney imaging. Nature Communications. 15(1). 9834–9834. 3 indexed citations
3.
Xu, Jiahui, Rui Luo, Zichao Luo, et al.. (2024). Ultrabright molecular scintillators enabled by lanthanide-assisted near-unity triplet exciton recycling. Nature Photonics. 19(1). 71–78. 34 indexed citations
4.
Yi, Zhigao, Li Zhang, Huan Chen, et al.. (2024). Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy. Journal of the American Chemical Society. 146(13). 9413–9421. 67 indexed citations breakdown →
5.
Liu, Yuxia, Jiahuan Tong, Xinyu Zhang, et al.. (2024). Solvent-mediated analgesia via the suppression of water permeation through TRPV1 ion channels. Nature Biomedical Engineering. 9(6). 905–916. 17 indexed citations
6.
Luo, Zichao, Yayun Wu, Yuenan Wang, et al.. (2023). Clinical radiation dose verification by topographic persistent luminescence dosimetry. Nano Today. 50. 101854–101854. 6 indexed citations
7.
Gao, Duyang, Zichao Luo, Yang He, et al.. (2023). Low‐Dose NIR‐II Preclinical Bioimaging Using Liposome‐Encapsulated Cyanine Dyes. Small. 19(17). e2206544–e2206544. 39 indexed citations
8.
Hou, Bo, Luying Yi, Di Hu, et al.. (2023). A swallowable X-ray dosimeter for the real-time monitoring of radiotherapy. Nature Biomedical Engineering. 7(10). 1242–1251. 57 indexed citations
9.
Ang, Melgious Jin Yan, Siew Yin Chan, Yi Yiing Goh, et al.. (2021). Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics. Advanced Drug Delivery Reviews. 178. 113907–113907. 59 indexed citations
10.
Mao, Duo, Fang Hu, Zhigao Yi, et al.. (2020). AIEgen-coupled upconversion nanoparticles eradicate solid tumors through dual-mode ROS activation. Science Advances. 6(26). eabb2712–eabb2712. 130 indexed citations
11.
Yu, Chaoheng, Zichao Luo, Meng Li, et al.. (2015). Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces long-lasting and balanced immune responses. Molecular Medicine Reports. 13(1). 915–924. 6 indexed citations
12.
Luo, Zichao, Shuai Shi, Ling Jin, et al.. (2015). Cationic micelle based vaccine induced potent humoral immune response through enhancing antigen uptake and formation of germinal center. Colloids and Surfaces B Biointerfaces. 135. 556–564. 18 indexed citations
13.
Xie, Binbin, Ling Jin, Zichao Luo, et al.. (2015). An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease. International Journal of Pharmaceutics. 490(1-2). 375–383. 94 indexed citations
14.
Li, Xingyi, Yuqin Wang, Chengbiao Yang, et al.. (2014). Supramolecular nanofibers of triamcinolone acetonide for uveitis therapy. Nanoscale. 6(23). 14488–14494. 30 indexed citations
15.
Li, Meng, Shi H, Yandong Mu, et al.. (2014). Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2. Molecular Cancer. 13(1). 179–179. 19 indexed citations
16.
Zhang, Yijuan, Hong Pan, Pengfei Zhang, et al.. (2013). Functionalized quantum dots induce proinflammatory responses in vitro: the role of terminal functional group-associated endocytic pathways. Nanoscale. 5(13). 5919–5919. 41 indexed citations
17.
Luo, Zichao, Ping Li, Jizhe Deng, et al.. (2013). Cationic polypeptide micelle-based antigen delivery system: A simple and robust adjuvant to improve vaccine efficacy. Journal of Controlled Release. 170(2). 259–267. 73 indexed citations
18.
Zhang, Ping, Dabing Yang, Zichao Luo, et al.. (2012). Gene therapy using the human telomerase catalytic subunit gene promoter enables targeting of the therapeutic effects of vesicular stomatitis virus matrix protein against human lung adenocarcinoma. Experimental and Therapeutic Medicine. 4(5). 859–864. 12 indexed citations
20.
Luo, Shan, Ping Chen, Zichao Luo, et al.. (2010). Combination of vesicular stomatitis virus matrix protein gene therapy with low‐dose cisplatin improves therapeutic efficacy against murine melonoma. Cancer Science. 101(5). 1219–1225. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026